A Win For Matinas BioPharma Holdings, Inc.
Mon, Sep 13, 2021 at 05:30 PM
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) jumped higher at $1.05, representing a gain of 27.1%. On Fri, Sep 10, 2021, MTNB:NYSEMKT hit a New 2-Week High of $0.83. The stock appeared on our News Catalysts scanner on Mon, Sep 13, 2021 at 08:55 AM in the 'BIOTECH' category. From Fri, Aug 27, 2021, the stock recorded 22.22% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT)
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Top 10 Gainers:
- aTyr Pharma, Inc. (LIFE:NASDAQ), 66.97%
- ATER (ATER:NASDAQ), 52.37%
- Itamar Medical Ltd. (ITMR:NASDAQ), 45.22%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 35%
- TMC (TMC:NASDAQ), 32.31%
- REGENXBIO Inc. (RGNX:NASDAQ), 31.2%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 27.12%
- UROY (UROY:NASDAQ), 24.29%
- Mayville Engineering Company, Inc. (MEC:NYSE), 24.28%
- BELLUS Health Inc. (BLU:NASDAQ), 21.94%